📰 Technology Platform News
Page 155 - Technology Platform News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Technology Platform. Real-time updates on events, politics, business and more.
December 23, 2022
/PRNewswire/ -- The "Exosome Therapeutics Market by Distribution by Target Indication, Therapeutic Area, Type of Formulation, Route of Administration and...
December 22, 2022
REGENXBIO Reports Update on Advancement of Programs for CLN2 Disease - read this article along with other careers information, tips and advice on BioSpace
December 22, 2022
REGENXBIO Inc. today announced a comprehensive program update to outline its progress and development plans for RGX-181 and RGX-381, both being developed as potential one-time gene therapies for the... | December 22, 2022
December 21, 2022
The new contract comes on the heels of the recent announcement of a $2.86 million contract renewal for a Fort Hood project and a proposed investment through Black Pearl Investments for TPT Smart City projectsSAN
December 21, 2022
/PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced a comprehensive program update to outline its progress and development plans for RGX-181 and...
December 21, 2022
Kite, a Gilead Company (Nasdaq: GILD), and Tmunity Therapeutics (Tmunity), today announced that the companies have signed an agreement in which Kite will acquire Tmunity, a clinical-stage, private biotech company focused on next-generation CAR T-therapies and technologies. The acquisition of Tmunity complements ...
December 21, 2022
Technology stocks are one of the hottest areas of the stock market and investors eagerly follow the latest developments in the space as it has a track record of providing quick returns and the potential...
December 20, 2022
2022 Was a Year of Product Innovation, Industry Recognition, Market Growth, and Expansion for the Creator of the AtlasFive® Technology Platform fo...
December 13, 2022
ADMA Biologics (NASDAQ:ADMA – Get Rating) and REGENXBIO (NASDAQ:RGNX – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, profitability and risk. Profitability This table compares ADMA Biologics and REGENXBIO’s net margins, […]
December 13, 2022
/PRNewswire/ -- The "Laboratory Informatics Market - A Global Market and Regional Analysis: Focus on Type, Offering, Component, Deployment, End User, and...